Safety and Pharmacokinetic Study of Inhaled Esketamine in Healthy Volunteers
Clinical trial NCT03407872 · COMPLETED
Trial details
- NCT number
- NCT03407872
- Sponsor
- Celon Pharma SA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-09
- Primary completion
- 2018-05-20
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.